Výsledky vyhledávání - "Dexter, Waters"

Akademický článek

A novel method for measuring the burden of breast cancer in neighborhoods

Autor: Russell K McIntire, Hee-Soon Juon, Scott W. Keith, Nicole L. Simone, Dexter Waters, Eleanor Lewis, Charnita Zeigler-Johnson

Publikováno v: Preventive Medicine Reports, Vol 33, Iss , Pp 102218- (2023)

Community-based breast cancer prevention efforts often focus on women who live in the same neighborhoods, as they tend to have similar demographic characteristics, health behaviors, and environmental exposures; yet little research describes methods o

Externí odkaz: https://doaj.org/article/57cce7a1e0e94b38a938d52eaa5919f8

Zobrazit plný text záznamu

Early prostate-specific antigen response among Black and non-Black patients with advanced prostate cancer treated with apalutamide

Autor: Vincent M, Bivins, Mike, Durkin, Ibrahim, Khilfeh, Carmine, Rossi, Frederic, Kinkead, Dexter, Waters, Patrick, Lefebvre, Dominic, Pilon, Lorie, Ellis

Publikováno v: Future Oncology. 18:3595-3607

Aim: To assess reduction in prostate-specific antigen (PSA) levels among Black and non-Black patients treated with apalutamide for non-metastatic castration-resistant prostate cancer (nmCRPC) or metastatic castration-sensitive prostate cancer (mCSPC)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ba88d6185e773f2297ac8ac3ee89503
https://doi.org/10.2217/fon-2022-0791

Zobrazit plný text záznamu

The Medical Home Initiative in Italy: an Analysis of Changes in Healthcare Utilization

Autor: Sarah E. Hegarty, Monica Pini, Scott W. Keith, M. Lombardi, Matthew Alcusky, Vittorio Maio, Dexter Waters, N. Jafari

Publikováno v: J Gen Intern Med

BACKGROUND: Seventeen medical homes (MHs) were established in the Local Health Authority (LHA) of Parma (about 450,000 residents), Emilia Romagna, Italy, between 2011 and 2016. OBJECTIVE: To estimate the effects of MH implementation on healthcare uti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae29a3a1710606230e345772e84e4575
https://doi.org/10.1007/s11606-021-07040-9

Zobrazit plný text záznamu

Real-world clinical outcomes of patients with localized prostate cancer (LPC) treated with external beam radiation therapy (EBRT)

Autor: Lawrence Ivan Karsh, Shawn Du, Jinghua He, Dexter Waters, Erik Muser, Neal D. Shore

Publikováno v: Journal of Clinical Oncology. 41:330-330

330 Background: Patients (pts) with localized prostate cancer (LPC) or locally advanced prostate cancer (PC) have several treatment options, including external beam radiation therapy (EBRT) and radical prostatectomy, which can be curative in some pts

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ed82c5dbdff8b9276b5388a06575ee11
https://doi.org/10.1200/jco.2023.41.6_suppl.330

Zobrazit plný text záznamu

Real-world prostate-specific antigen (PSA) response and disease progression among patients with non-metastatic castration-resistant prostate cancer (nmCRPC) initiated on apalutamide (APA)

Autor: Benjamin H Lowentritt, Shawn Du, Carmine Rossi, Frederic Kinkead, Dexter Waters, Bronwyn Moore, Patrick Lefebvre, Dominic Pilon, Erik Muser

Publikováno v: Journal of Clinical Oncology. 41:69-69

69 Background: For patients with nmCRPC, APA with androgen deprivation therapy is an important therapeutic option with demonstrated efficacy in improving metastasis-free survival (MFS), and other clinical outcomes. However, there is limited real-worl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1c2896cbcd6ad33d4320a33fd56124bd
https://doi.org/10.1200/jco.2023.41.6_suppl.69

Zobrazit plný text záznamu

Real-world time-to-castration resistance (CR) among patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) initiating apalutamide (APA), enzalutamide (ENZ), or abiraterone acetate (ABI) from an oncology database

Autor: Benjamin H Lowentritt, Carmine Rossi, Shawn Du, Erik Muser, Frederic Kinkead, Dexter Waters, Patrick Lefebvre, Dominic Pilon, Neeraj Agarwal

Publikováno v: Journal of Clinical Oncology. 41:65-65

65 Background: CR is an important clinical indicator of disease progression and worsening overall survival among pts with mCSPC. This study describes real-world time-to-CR progression in an oncology setting among pts with mCSPC who initiated APA, ENZ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::38c1ea95f6d8a9d614432191431e5b18
https://doi.org/10.1200/jco.2023.41.6_suppl.65

Zobrazit plný text záznamu

Time-to-next treatment (TTNT) and overall survival (OS) among homologous recombination repair (HRR) positive and HRR negative patients with metastatic castration-resistant prostate cancer (mCRPC) initiating first-line (1L) therapy

Autor: Mehmet Asim Bilen, Ibrahim Khilfeh, Carmine Rossi, Erik Muser, Laura Morrison, Annalise Hilts, Dexter Waters, Patrick Lefebvre, Dominic Pilon, Daniel J. George

Publikováno v: Journal of Clinical Oncology. 41:80-80

80 Background: Several recurrent mutations that interfere with the HRR DNA damage signaling response pathway have been recently identified as novel biomarkers that may help optimize treatment for patients with mCRPC. There is limited real-world infor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6da1d7f554d393bc727157492e778c14
https://doi.org/10.1200/jco.2023.41.6_suppl.80

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání